Hims & Hers Acquires At-Home Lab Testing Facility

The health and wellness platform is entering the whole body testing space, including perimenopausal and menopausal support
Hims & Hers has acquired Trybe Labs (also known as Sigmund NJ LLC), a New Jersey-based at-home lab testing facility—a move that expands the health and wellness platform’s offerings to include at-home blood draws and supports its plans to enter new areas, including low testosterone treatment and perimenopausal and menopausal support.
The service uses blood lancets instead of traditional needles, allowing members to test for various health metrics, including hormone levels, cardiac risk, stress markers, cholesterol, liver and thyroid function and prostate health. Based on the results, Hims & Hers healthcare providers create personalized treatment plans encompassing nutrition, lifestyle changes, supplements and medication recommendations.
The at-home testing is expected to roll out to Hims & Hers customers over the next year.
“The healthcare that customers expect and deserve today is on-demand care with treatments designed specifically for them,” Hims & Hers chief medical officer Dr. Patrick Carroll said. “This next generation of healthcare is what we’re building at Hims & Hers by providing the best information and set of options to each customer that comes to our platform so they can access precisely the care that is best for them.”
Hims & Hers plans to use de-identified lab data to enhance its artificial intelligence capabilities, particularly MedMatch, which was launched in 2023. The system uses artificial intelligence and machine learning to help healthcare providers determine optimal treatment plans and dosages for each patient.
“Access to richer data allows us to deepen the insights that providers can use on our platform to guide their clinical decisions for each individual patient,” Dr. Carroll said. “At-home lab testing is one more exciting step towards elevating the personal, comprehensive care customers in this country should expect.”

Earlier this month, Hims & Hers also announced two new programs: the Hims & Hers Health Collective and the Hims & Hers Community Member Council. The Collective, an application-based program, gives customers a chance to connect and support one another and comes with the perk of being among the first to learn about new products. The Council serves as an exclusive group of 15 hand-selected Hims & Hers members who will help influence the platform’s future and its products, services and experiences.
“At Hims & Hers, we’re successful when our customers are,” chief commercial officer Mike Chi said. “The long-term success and well-being of each individual customer is at the center of everything we do. By partnering with and listening to our customers’ needs, we are able to make even better improvements to their experience and care. We are not just changing how healthcare works—we are helping to build a system that truly serves the people it was meant to help.”